NTRA News and Press, Natera Inc. From 01/22/24

Invitae Completes Sale of Reproductive Health Assets to Natera PR Newswire SAN FRANCISCO , Jan. 22, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has completed the sale of certain reproductive health as...

Oral presentations include updated 24-month DFS analysis from GALAXY and first interim analysis from BESPOKE CRC Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that new data on its personalized and tumor-informed molecular residual disease (MR...

2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...

2024-01-17 15:51:07 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Piper says RavGen decision largely removes legal ove...

2024-01-17 14:27:40 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera says jury reached verdict of no willful infri...

2024-01-17 09:23:00 ET U.S. stock index futures on Wednesday were in the red, as some concerns over the trajectory of anticipated interest rate cuts from the previous session continued to weigh on sentiment. Moreover, retail sales data came in hotter-than-expected. Here are some stocks to w...

2024-01-16 17:30:34 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera raises FY23 revenue guidance by $20M to $1.07...

No willful infringement, damages significantly less than what Ravgen was seeking Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that a jury has reached a verdict in the United States District Court for the Western District of Texas regarding a p...

2024-01-16 11:49:56 ET More on iShares Russell 1000 Growth ETF: IWF: Price Isn't Everything; Favor Growth Over Value Citi’s 30 stocks for its 2024 top themes Top overweight stocks with high growth and low volume - MS Seeking Alpha’s Quant Rating...

Shares of Natera, Inc. (NASDAQ: NTRA) traded at a new 52-week high today and are currently trading at $37.53. So far today, approximately 1.19M shares have been exchanged, as compared to an average 30-day volume of 1.17M shares. Natera, Inc., a diagnostics company, develops and commercializes...